PALAVI REDDY: Open Payments
NPI 1831420090 · PEACHTREE CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 75 payments from 20 companies in 2025. Trend: 2023 $772 · 2024 $895 · 2025 $1,430
Food & beverage: $1,430
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $241 |
| Lilly USA, LLC | 11 | $188 |
| Axsome Therapeutics, Inc. | 6 | $173 |
| ABBVIE INC. | 13 | $157 |
| Novo Nordisk Inc | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| PFIZER INC. | 5 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
| Antares Pharma, Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
Products named: AIRSUPRA, MOUNJARO, Symbravo, VRAYLAR, REXULTI, FARXIGA, NURTEC ODT, XIFAXAN.
Industry payments across GA — which companies pay providers there.
